Lost password ?
UNIMED
Top-line and Bottom-line downgraded
- "A lower exposure to export markets (37.7% in H1 2020 vs. 45.3% in 2019) will weigh on the pharmaceutical laboratory’s profitability. Indeed, we expect an average EBITDA margin of 31.3% over the ..."
Executive summary
Conflicts of Interest
FIND A REPORT
SIMPLE, TO THE POINT IDEA GENERATION
Each company is researched in depth using a structured, robust and transparent process. Valuations are disciplined and dispassionate.
AlphaMena allows you to compare stocks along a wide range of parameters be it by sector, by geography or an array of investment themes.
Our reports include actuarial as well as off balance-sheet data and governance metrics.
Priority is given to idea generation through quick, to the point, answers by means of browsing from one idea to the next.